Arvinas (ARVN) Accumulated Expenses (2017 - 2022)
Arvinas' Accumulated Expenses came in at $30.2 million for Q1 2022, up 277.4% from $8 million a year earlier and up 30.7% from the prior quarter.
Analysis
Arvinas (ARVN) Accumulated Expenses (2017 - 2022) Analysis & Trends
At the end of FY2021, Arvinas' Accumulated Expenses was $23.1 million, up 22.2% from FY2020.
- Accumulated Expenses has increased in each of the last four years, with a four-year compound annual growth rate of 59.8% (FY2017 to FY2021).
- Going back by year, Accumulated Expenses was $18.9 million in FY2020 (+148.6%), $7.6 million in FY2019 (+90.0%), $4 million in FY2018 (+12.8%) and $3.55 million in FY2017.
- The Q1 2022 figure represents the highest quarterly Accumulated Expenses in data going back to Q4 2017.
- Year-over-year, Accumulated Expenses has increased for 11 consecutive quarters, with growth averaging 92.7% over the last eight quarters.
- The year-over-year growth in Accumulated Expenses has ranged between 12.8% (Q4 2018) and 277.4% (Q1 2022) over the last five years.
- Business Quant data shows ARVN's Accumulated Expenses at $23.1 million (Q4 2021), $13.77 million (Q3 2021) and $13.47 million (Q2 2021) in the three quarters before Q1 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Arvinas | 453.26 Mn | -1.97 Bn | 400,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 30.20 Mn |
| Dec 31, 2021 | 23.10 Mn |
| Sep 30, 2021 | 13.77 Mn |
| Jun 30, 2021 | 13.47 Mn |
| Mar 31, 2021 | 8.00 Mn |
| Dec 31, 2020 | 18.90 Mn |
| Sep 30, 2020 | 12.14 Mn |
| Jun 30, 2020 | 7.40 Mn |
| Mar 31, 2020 | 6.78 Mn |
| Dec 31, 2019 | 7.60 Mn |
| Sep 30, 2019 | 6.23 Mn |
| Jun 30, 2019 | 4.00 Mn |
| Mar 31, 2019 | 2.95 Mn |
| Dec 31, 2018 | 4.00 Mn |
| Sep 30, 2018 | 4.85 Mn |
| Dec 31, 2017 | 3.55 Mn |
API Access
Arvinas Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ARVN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "ARVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ARVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();